Objectives: Identification of the clinical spectrum and the electrophysiological responses of a Saudi population with Parkinson's disease as opposed to a matched normal population.
Methods: Fifty four subjects (41 males and 13 females) were selected for the study. The patients were clinically evaluated for the occurrence of Parkinson's disease symptoms, as well as other associated medical conditions. All patients had brain computerized tomography scans. Electrophysiological tests were performed on all patients using the Medelec ST 10 Sensor 59394 Model. These tests included somatosensory evoked response of median nerves, brain stem auditory evoked responses and visual evoked responses. The significant differences in these evoked responses between the patients with Parkinson's disease and normal patients were statistically evaluated.
Results: Twenty six out of the 40 computerized tomography brain scans which had been carried out showed normal brain morphology and 5 had a clear evidence of cerebrovascular disease while only 9 showed distinctive brain atrophy. The mean values for the brain stem auditory evoked response, the somatosensory evoked response and the visual evoked responses were higher in patients with Parkinson's disease as compared to those who did not have the disease. Significant differences were only seen as prolonged latencies in median nerve somatosensory evoked response, as well as delayed waves I and V on the brain stem auditory evoked response. Inter-wave latencies, however, were not significantly different.
Conclusion: Parkinson's disease in a Saudi population showed significant differences to somatosensory evoked response and brain stem auditory evoked response electrophysiological data as compared to age-matched controls, however, the clinical characteristics of Parkinson's disease in Saudi patients are not significantly different from those reported for patients elsewhere.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Polystyrene Nanoplastics Hitch-Hike the Gut-Brain Axis to Exacerbate Parkinson's Pathology.
ACS Nano
January 2025
Nanomedicine Center, The Great Bay Area National Institute for Nanotechnology Innovation, 136 Kaiyuan Avenue, Guangzhou 510700, China.
The neurological implications of micro- and nanoplastic exposure have recently come under scrutiny due to the environmental prevalence of these synthetic materials. Parkinson's disease (PD) is a major neurological disorder clinically characterized by intracellular Lewy-body inclusions and dopaminergic neuronal death. These pathological hallmarks of PD, according to Braak's hypothesis, are mediated by the afferent propagation of α synuclein (αS) via the enteric nervous system, or the so-called gut-brain axis.
View Article and Find Full Text PDFInsulin resistance compromises midbrain organoid neuronal activity and metabolic efficiency predisposing to Parkinson's disease pathology.
J Tissue Eng
January 2025
Developmental and Cellular Biology, Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg.
Growing evidence indicates that type 2 diabetes (T2D) is associated with an increased risk of developing Parkinson's disease (PD) through shared disease mechanisms. Studies show that insulin resistance, which is the driving pathophysiological mechanism of T2D plays a major role in neurodegeneration by impairing neuronal functionality, metabolism and survival. To investigate insulin resistance caused pathological changes in the human midbrain, which could predispose a healthy midbrain to PD development, we exposed iPSC-derived human midbrain organoids from healthy individuals to either high insulin concentration, promoting insulin resistance, or to more physiological insulin concentration restoring insulin signalling function.
View Article and Find Full Text PDFPeptide-based amyloid-beta aggregation inhibitors.
RSC Med Chem
December 2024
Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research Sector 67, S. A. S. Nagar Punjab 160062 India
Aberrant protein misfolding and accumulation is considered to be a major pathological pillar of neurodegenerative disorders, including Alzheimer's and Parkinson's diseases. Aggregation of amyloid-β (Aβ) peptide leads to the formation of toxic amyloid fibrils and is associated with cognitive dysfunction and memory loss in Alzheimer's disease (AD). Designing molecules that inhibit amyloid aggregation seems to be a rational approach to AD drug development.
View Article and Find Full Text PDFTheta and beta power in the subthalamic nucleus responds to conflict across subregions and hemispheres.
Brain Commun
January 2025
Department of Neurological Surgery, University of Louisville, Louisville, KY 40202, USA.
The subthalamic nucleus is thought to play a crucial role in controlling impulsive actions. Networked among the basal ganglia and receiving input from several cortical areas, the subthalamic nucleus is well positioned to influence action selection when faced with competing and conflicting action outcomes. The purpose of this study was to test the dissociable roles of the dorsal and ventral aspects of the subthalamic nucleus during action conflict in patients with Parkinson's disease undergoing intraoperative neurophysiological recording and to explore a potential mechanism for this inhibitory control.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!